|
Kathryn L. Xixis, MD
|
Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Neurology Committee Member to ACGME-ABMS Symposium on CBME (hotel and travel expenses) with ACGME. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Child Neurology Representative to ABPN Critical Issues Forum (on CBME) (hotel and travel expenses) with ABPN. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker (Honorarium) with Oklahoma State Graduate Medical Â鶹´«Ã½Ó³» Committee. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³» Â鶹´«Ã½Ó³» Committee Member (hotel and travel expenses) with Â鶹´«Ã½Ó³». Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a UCNS Accreditation Council (hotel and travel expenses) with UCNS. Dr. Xixis has a non-compensated relationship as a Podcast Writer and Editor of CNS Podcast Brainstorm with Child Neurology Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
Robert J. Fox, MD, FÂ鶹´«Ã½Ó³»
(Cleveland Clinic)
|
Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care. |
|
Howard J. Rosen, MD
(UCSF)
|
Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to Â鶹´«Ã½Ó³» interests or activities. |